Redx Pharma Financials

£30.3 M

Mkt cap, 24-May-2017
Net income (FY, 2016)(15.5 M)
EBITDA (FY, 2016)(14.8 M)
EBIT (FY, 2016)(14.9 M)
Closing share price, 24-May-20170.3
Cash, 30-Sep-20165.8 M
EV26.5 M

Market Value

Revenue/Financials

Income Statement

Annual

GBPFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.3 m

Operating expense total

4.9 m

EBITDA

(3.5 m)(9.2 m)(14.8 m)

EBITDA margin, %

(272%)

EBIT

(3.6 m)(4 m)(9.4 m)(14.9 m)

EBIT margin, %

(276%)

Pre tax profit

(3.8 m)(4.3 m)(8.8 m)(15.4 m)

Income tax expense

389.2 k910 k650 k(114 k)

Net Income

(3.4 m)(3.4 m)(8.2 m)(15.5 m)

    Balance Sheet

    Annual

    GBPFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

    Cash

    515.8 k45.8 k1 m2.9 m9.4 m5.8 m

    Accounts Receivable

    112.9 k331.9 k2.7 m114 k452 k469 k

    Current Assets

    628.7 k377.7 k4.4 m6.6 m12.3 m7.9 m

    PP&E

    44.9 k32 k327.2 k130 k353 k533 k

    Goodwill

    309 k309 k309 k

    Total Assets

    967.6 k688.1 k5 m7.1 m13.8 m9.4 m

    Accounts Payable

    1 m483.2 k1.4 m1.2 m1.6 m1.6 m

    Current Liabilities

    1 m483.2 k4.5 m5.2 m4.1 m7.7 m

    Non-Current Liabilities

    865.3 k2 m

    Total Debt

    2 m

    Total Liabilities

    1 m1.3 m4.5 m5.2 m6.1 m7.7 m

    Additional Paid-in Capital

    3.5 k4.1 k5.6 k7 k650 k936 k

    Retained Earnings

    (3.4 m)(3.4 m)(8.2 m)(15.5 m)

    Total Equity

    (34.9 k)(660.4 k)415.1 k1.8 m7.7 m1.7 m

    Debt to Equity Ratio

    1.2 x

    Debt to Assets Ratio

    0.2 x

    Financial Leverage

    -27.7 x-1 x11.9 x3.9 x1.8 x5.5 x

      Cash Flow

      Annual

      GBPFY, 2013FY, 2014FY, 2015FY, 2016

      Net Income

      (3.4 m)(3.4 m)(8.2 m)(15.5 m)

      Cash From Operating Activities

      (3.9 m)(2.2 m)(6.5 m)(12.5 m)

      Cash From Financing Activities

      5.2 m4.1 m13.4 m9.3 m

      Net Change in Cash

      968.1 k1.9 m6.5 m(3.7 m)

      Income Taxes Paid

      910 k650 k(114 k)

        Ratios

        Y, 2016

        EV/EBITDA

        -1.8 x

        EV/EBIT

        -1.8 x

        EV/CFO

        -2.1 x

        Debt/Equity

        1.2 x

        Debt/Assets

        0.2 x

        Financial Leverage

        5.5 x